SEIZURES AND EPILEPSY 3 Flashcards

1
Q

GOALS OF THERAPY

A

Individualized goals of therapy
Ideal: Complete seizure freedom
Reduce frequency of seizures (1/3 of patients)
Balance between seizure control and adverse
effects of antiseizure medications
Improve quality of life
Treatment goals to be reviewed at follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NON-PHARMACOLOGICAL

A

 Avoid individual precipitants
 Sleep deprivation
 Avoid drug abuse e.g. cocaine, amphetamines
 Minimize alcohol intake
 Patient to consult pharmacist or health care provider when
starting or stopping any complementary and alternative
medicine (CAM) products e.g. herbal supplements
 Seizure precautions, examples
 Driving restrictions
 Avoid heights, power tools to avoid accidental injury
 Bathing, swimming, caring for young children precautions

 Ketogenic diet
- High fat diet, no carbohydrate, and adequate protein diet.
no carbohydrate diet, so there is no glucose and the body will use the fat as a source of energy instead. That the liver will switch the fats into fatty acids. And fatty acids gets metabolized to ketone bodies. And actually they found out the ketone, ketone bodies can be used by the brain as a source and alternative source of energy.
Controls seuizres
ketogenic diet had proven effective also in status epilepticus
 Vagus Nerve Stimulation: : Providing electrical impulses through the vagal nerve. And it’s proven useful in some cases of intractable epilepsy, select resistant drug resistant epilepsy
 Epilepsy surgery: focal epilepsyy and drug resistant (eh/ remove temporal lobe of brain)
 Cannabis: there’s some conflicting evidence in term of using recreational cannabis to control seizures. Actually, one of the ingredients in cannabis, cannabidiol, this I actually have proven in clinical trials to be effective in controlling seizures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PRINCIPLES OF THERAPY

decisiion to treat

A

 Not all seizures need to be treated
 To treat or not to treat after the first seizure
 Questions to ask:
 Did an external precipitant cause the seizure?
 Can precipitants be avoided?
 Will seizure recur? . Two unprovoked seizure separated by more than 24 h, correct? Or one unprovoked seizure, and the risk of seizure is increased more than 60%. If you see any EEG abnormalities, we say this patient is at high risk of seizure
 EEG abnormalities
 Presence of a remote cause of increase risk
 Neurological examination
 How disabling are the seizures?
 Risk/benefit ratio for ASM therapy

Treat if
The patient experienced 2 or more unprovoked
seizures
The patient experienced a seizure and provoked
from some acquired causes such as stroke,
meningitis, brain injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Initiation of Antiseizure Medication (ASM) therapy

A

 Start with one first line agent
 Start with fraction of the target dose and titrate up
(exceptions phenytoin and phenobarbital)
 Allow adequate time to assess the efficacy unless toxicity,
severe adverse drug reaction
 If seizures were not controlled, check:
 if the selected ASM is effective in the patient’s seizure type
 if the ASM dose was sufficient
 if the patient was adherent
 for any drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DOSE TITRATION

A

 Slow titration might alleviate ADRs
 Carbamazepine  nausea, vomiting, drowsiness
 Topiramate  cognitive impairment
 Lamotrigine  rash
 Gabapentin  CNS adverse effects
 Slower titration is recommended when lamotrigine given
with valproic acid: valproic acid is a liver microsomal enzyme inhibition, inhibitor. It inhibits the metabolism of lamotrigine. And so the exposure to lamotrigine is way higher, like you need to be way slower
 Some agents can be given at target dose with no titration
 Phenytoin, phenobarbital, levetiracetam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PRINCIPLES OF THERAPY
 If monotherapy fails

A

Try another first line agent before adding second
agent
Why?
 Less adverse reactions
 Less drug interactions
 Less cost
 Better adherence
 And, similar efficacy and tolerability

 If monotherapy still fails (after 2-3 agents being
tried)
Add a second agent
Consider synergy in mechanism and antagonism
for adverse ractions if possible
~ 30% will need polytherapy
~ 10 % refractory to all ASMs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ASM Switch

A

 Titrate up the new agent faster than titrating down the
old agent (dose change every 3-5 half-lives)
 Preferable to titrate to full dose before tapering the old
agent
 Monitor for worsening seizure control or adverse
reactions during switch
 In case of life-threatening adverse reactions, the old
agent should be stopped immediately and the new
agent should be fast titrated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When to stop?

A

 Consider if patient has been seizure free for
 two or more years (non-acquired)
 6-12 months (acquired cases such as stroke and
meningitis)
 Pros: less cost, no adverse reactions, less life style
restrictions
 Cons: risk of relapse, status epilepticus, harm, loss of
driving privileges
 Seizure recurrence is highest in the first year after ASM
withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How to stop?

A

SLOW taper is recommended (months – e.g. decrease
by 25% every 2-4 weeks)
 If patient on more than one ASM:
 Taper ASMs separately
 Least beneficial or most toxic ASMs to be withdrawn
first
 Seizure precautions e.g. driving avoidance should be
followed during withdrawal
 If seizures recur, restart therapy, could be indefinite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

COUNSELLING AND MONITORING

A

 Stress on adherence
 Efficacy
 ADRs and Toxicity
 Short-term ADRs
 Long-term ADRs
 Major ADRs
 Labs
 CBC, LFTs (lytes) at baseline
 Repeat 4-8 weeks after starting drug then every year
 May be done more frequently in symptomatic patients
 Drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GENERIC SUBSTITUTION

A

Controversy about generic substitution and link to poor
seizure control
 American Epilepsy Society Position Statement (2016):
 Drug formulation substitution reduces cost but does not
compromise efficacy
 Patient counseling is very important

patient needs to be aware that this change might not change the efficacy, but you never know what will happen. And patient might have increased risk for seizures or something like that, need to be monitored frequently if they’re switching from one generic to another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

FACTORS GUIDING THERAPY

A

 Seizure type/epilepsy syndrome
 Drug pharmacokinetics
 Drug interactions: DOAC abs contraindicated
 Adverse effects profile
 Cost and drug coverage
 Patient’s comorbidities
 Patient’s age, sex, life style
 Effect on pregnancy and lactation
 Patient preferences
 Convenience of dosing e.g. once vs twice daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SPECIAL POPULATION
Contraception

A

Contraception
 Decreased Effectiveness of OCs by enzyme-inducing ASMs
 Options
 Use high-dose estrogen OCs (> 50ug estrogen) – not available
anymore in Canada
 Use back-up method of contraception
 Consider non-interacting ASMs
 Estrogens might reduce the concentration of lamotrigine

So that’s important to monitor lamotrigine level if the patient starts on an oral contraceptive.

Decrease liver enzyme ASML phenytoin, phenobarb, primidone, carbamazepine, topirmate high dose

they decrease the effectiveness of oral contraceptives because it increases metabolism of those hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pregnancy

A

A balance needs to be achieved between seizure
control and minimizing the risk to fetus
 Effects of Seizures:
 Seizures in 1st trimester increase risk of malformations
 Seizures (especially tonic-clonic) increase the risk of
maternal and fetal hypoxia
 Pregnancy reduces ASMs levels (esp. in 3rd trimester)
 Potential for non-adherence
 Risk of malformation doubles with ASM (4-6 vs. 2-
3%)
 No ASM is absolutely safe
 Valproic acid is the least favorable among ASMs
 Pregabalin: Concern about causing major birth defect
following exposure in the first trimester (6 vs 2%)

anti-seizure meds double the risk of malformation as well
seizures, especially the tonic clonic, the red one increase the risk for maternal and fetal hypoxia.

Lamotrigine can cause breakthru seizures cuz pregancy in Vd increases and drug will distribute further
- In addition, hormones can increase lamotrigine metabolism
- You measure a steady-state level prior to pregnancy If it’s planned
- monitor that every trimester, targer the dose
- If unplanned preg, do a level to see therapeutic conc
importantly, after the patient delivers the baby, their metabolism will go back to normal very quickly within days. This means if the patient was on humungous those lamotrigine after delivery, this Lamotrigine dose has to go down quickly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pregnancy
 Management principles

A

 If patient was controlled on an agent before pregnancy,
continuing same agent preferred
 Exceptions: valproic acid
 Monotherapy is preferred
 TDM is recommended to maintain lowest effective dose
and to account for PK changes e.g. lamotrigine
 Avoid triggers e.g. sleep deprivation
 Stress on compliance
 Avoid smoking, alcohol and illicit drugs
 Multivitamins, folic acid (1 mg

The one that’s big no, is valproic acid is the least favorable among anti-seizure meds given the evidence that actually causes lots of malformation.

IF CHILD-BEARING DONT USE VALPROIC ACID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

BREASTFEEDING

A

All ASMs pass into breast milk
Discussion with parents
Risk vs benefit

IF IT GOES INTO BRAIN IT WILL GO INTO THE MILK

17
Q

STATUS EPILEPTICUS

A

 A neurological emergency
 Convulsive or non-convulsive
 Definition: Continuous clinical or EEG seizure activity
that lasts 5 or more minutes or recurrent seizures
without return to baseline among seizures
 Complications
 Increased brain activity and metabolic demand will lead to
CNS hypoxia and glycopenia
 Overall mortality <30% in adults, <3% in pediatrics

18
Q

STATUS EPILEPTICUS management

A

Management
 Phase I: Benzodiazepines
 IV Lorazepam, IM midazolam, IV diazepam
 Dose may be repeated
 Phase II
 Phenytoin 20 mg/kg IV bolus
 Valproic acid or levetiracetam could be alternatives
 Second line: Phenobarbital
 Maintenance dose to be continued
 Phase III: Refractory Status Epilepticus
 Requires intubation, administration of infusions of
midazolam, propofol and/or phenobarbital or pentobarbital

19
Q

what to do w/ lamotrigine in pregnancy

A

Anti-seizure meds could cause harm to the baby.
anti-seizure meds double the risk of malformation as well

seizures, especially the tonic clonic, the red one increase the risk for maternal and fetal hypoxia.

SO THEY ARE BOTH BAD

Lamotrigine can cause breakthru seizures cuz pregancy in Vd increases and drug will distribute further
- In addition, hormones can increase lamotrigine metabolism
- You measure a steady-state level prior to pregnancy If it’s planned
- monitor that every trimester, targer the dose
- If unplanned preg, do a level to see therapeutic conc
importantly, after the patient delivers the baby, their metabolism will go back to normal very quickly within days. This means if the patient was on humungous those lamotrigine after delivery, this Lamotrigine dose has to go down quickly